Genomma Lab Internacional Announces Seventeenth Dividend Payment
Genomma Lab Internacional has announced the payment of its seventeenth dividend. The company has submitted regulatory filings regarding the dividend distribution.
Mexico City – Genomma Lab Internacional, a pharmaceutical and personal care products company with operations in Mexico and international expansion, announced on September 22, 2026, that it will issue its seventeenth dividend payment. The company filed the necessary information with regulatory bodies.
While specific details regarding the amount and payment date of this seventeenth dividend have not yet been disclosed, it represents a continuation of the company's financial distribution policy to its shareholders.
Genomma Lab, publicly traded on the Mexican Stock Exchange under the ticker symbol LABB, has established a significant presence in the personal care and pharmaceutical sectors.
Further information on the dividend is expected to be released in subsequent communications.